Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TXG · NASDAQ · Laboratory Analytical Instruments
$51.80−5.58 (−9.72%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
10x Genomics (TXG) · oqro.io/stocks/TXG · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Planned sale · Planned for Nov 20, 2026 · Notice filed Nov 20, 2026
Director filed to sell about $223K of TXG stockSourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Viking Global disclosed a new position in TXG for Q3 2026SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office no longer reported TXG for Q3 2026SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed an increased position in TXG for Q3 2026SourceInsider trade · Traded Nov 10, 2026 · Filed Nov 13, 2026
CEO sold ~$1.95M of TXG shares in the open marketSourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 13, 2026
ARK Investment Management disclosed a reduced position in TXG for Q3 2026SourceFederal contract · Signed Sep 28, 2026 · Updated Oct 5, 2026
Department of Veterans Affairs awarded 10x Genomics, Inc.: $199K obligated to dateSourceFederal contract · Signed Sep 28, 2026 · Updated Sep 28, 2026
Department of Health and Human Services awarded 10x Genomics, Inc.: $301K obligated to dateSourceFederal contract · Signed Sep 23, 2026 · Updated Sep 23, 2026
Department of Health and Human Services awarded 10x Genomics, Inc.: $95K obligated to dateSourceFederal contract · Signed Sep 22, 2026 · Updated Sep 22, 2026
Department of Health and Human Services awarded 10x Genomics, Inc.: $250K obligated to dateSourceFederal contract · Signed Sep 21, 2026 · Updated Sep 21, 2026
Department of Health and Human Services awarded 10x Genomics, Inc.: $120K obligated to dateFederal contract · Signed Aug 27, 2026 · Updated Aug 31, 2026
Department of Health and Human Services awarded 10x Genomics, Inc.: $560K obligated to dateSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Samlyn Capital, LLC disclosed a new position in TXG for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Duquesne Family Office disclosed a new position in TXG for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
ARK Investment Management disclosed a reduced position in TXG for Q2 2026Federal contract · Signed Jun 15, 2026 · Updated Jun 15, 2026
Department of Veterans Affairs awarded 10x Genomics, Inc.: $350K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a reduced position in TXG for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
ARK Investment Management disclosed a reduced position in TXG for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 7, 2026
Amova Asset Management Americas, Inc. disclosed a reduced position in TXG for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates disclosed a new position in TXG for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
ARK Investment Management disclosed an increased position in TXG for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
Amova Asset Management Americas, Inc. disclosed an increased position in TXG for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
ARK Investment Management disclosed a reduced position in TXG for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
Amova Asset Management Americas, Inc. disclosed a reduced position in TXG for Q3 2025SourceInsider trade · Traded Aug 22, 2025 · Filed Aug 26, 2025
CFO sold ~$308K of TXG shares in the open marketSourceInsider trade · Traded Aug 22, 2025 · Filed Aug 26, 2025
CEO sold ~$129K of TXG shares in the open marketSourceInsider trade · Traded Aug 22, 2025 · Filed Aug 26, 2025
Director sold ~$103K of TXG shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deerfield Management Company, L.P. disclosed a reduced position in TXG for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Jul 30, 2025
ARK Investment Management disclosed an increased position in TXG for Q2 2025SourceInsider trade · Traded May 22, 2025 · Filed May 27, 2025
CEO sold ~$78K of TXG shares in the open marketSourceInsider trade · Traded May 22, 2025 · Filed May 27, 2025
CFO sold ~$34K of TXG shares in the open marketSourceInsider trade · Traded May 22, 2025 · Filed May 27, 2025
Director sold ~$62K of TXG shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Ra Capital Management, L.P. disclosed a reduced position in TXG for Q1 2025SourceInsider trade · Traded Feb 28, 2025 · Filed Mar 4, 2025
CEO sold ~$84K of TXG shares in the open marketSourceInsider trade · Traded Feb 24, 2025 · Filed Feb 26, 2025
CEO sold ~$56K of TXG shares in the open marketSourceInsider trade · Traded Feb 24, 2025 · Filed Feb 26, 2025
Director sold ~$51K of TXG shares in the open marketSourceInsider trade · Traded Feb 21, 2025 · Filed Feb 25, 2025
Director purchased ~$446K of TXG shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. disclosed a new position in TXG for Q4 2024SourceInsider trade · Traded Nov 22, 2024 · Filed Nov 25, 2024
CEO sold ~$92K of TXG shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 25, 2024
Director sold ~$79K of TXG shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Generation Investment Management LLP no longer reported TXG for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deerfield Management Company, L.P. disclosed an increased position in TXG for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Oct 31, 2024
ARK Investment Management disclosed an increased position in TXG for Q3 2024SourceFederal contract · Signed Aug 20, 2026 · Updated Sep 9, 2026
Department of Health and Human Services awarded 10x Genomics, Inc.: $64K obligated to dateSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed a reduced position in TXG for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Jacobs Levy Equity Management, Inc disclosed a reduced position in TXG for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Amova Asset Management Americas, Inc. disclosed a reduced position in TXG for Q2 2026SourceFederal contract · Signed Aug 5, 2026 · Updated Aug 5, 2026
Department of Agriculture awarded 10x Genomics, Inc.: $127K obligated to dateSourceFederal contract · Signed Aug 4, 2026 · Updated Aug 4, 2026
Department of Agriculture awarded 10x Genomics, Inc.: $134K obligated to dateSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Ra Capital Management, L.P. disclosed a reduced position in TXG for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 11, 2025
Amova Asset Management Americas, Inc. disclosed an increased position in TXG for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 7, 2025
ARK Investment Management disclosed an increased position in TXG for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 7, 2025
Amova Asset Management Americas, Inc. disclosed a reduced position in TXG for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 10, 2025
Amova Asset Management Americas, Inc. disclosed a reduced position in TXG for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 4, 2025
ARK Investment Management disclosed an increased position in TXG for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 7, 2024
Amova Asset Management Americas, Inc. disclosed an increased position in TXG for Q3 2024Source